Anzeige
Mehr »
Dienstag, 01.09.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D3KD | ISIN: US50535E1082 | Ticker-Symbol: N/A
1-Jahres-Chart  (nicht börsennotiert)
PROSOMNUS INC Chart 1 Jahr

Aktueller Chart PROSOMNUS Aktie

Chart vergleichen mit:

Firmenname, WKN, ISIN oder Aktien-Kürzel

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%
Chart-Typ:
Zeitraum:
 
PROSOMNUS INC-Investoren interessieren sich auch für diese Wertpapiere
Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of DirectorsARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026....
► Artikel lesen
Privia Health Group, Inc.: Privia Health Reports Strong Second Quarter and Year-to-Date 2026 Results2Q'26 Net Income of $9.0M, +236.7% from 2Q'252Q'26 Adjusted EBITDA of $37.4M, +29.1% from 2Q'25Full-Year 2026 Guidance Raised for All Key Financial Metrics ARLINGTON, Va., Aug. 06, 2026 (GLOBE NEWSWIRE)...
► Artikel lesen
Biotech Stocks Hit 52-Week Highs - The Oncology Institute, Inhibikase Therapeutics, Alto Neuroscience, Elevance Health, Privia HealthWASHINGTON (dpa-AFX) - These biotech stocks touched a 52-week high on July 14, 2026, attributable to key catalysts like announced offerings to increase capital and the expansion of business...
► Artikel lesen
Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly HalfFUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting...
► Artikel lesen
Biotech Stocks At 52-Week Highs - Vogenx, Pharvaris, Solventum, Inhibikase Therapeutics, HeartFlowWASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 24, 2026, driven by positive results from clinical trials or an upcoming conference participation. Vogenx...
► Artikel lesen
Heartflow, Inc.: Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 GuidanceSAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing coronary artery disease (CAD), today reported financial results...
► Artikel lesen
Morning Market Movers: Ameresco, Inno Holdings, AdaptHealth, Ibotta See Big SwingsOTTAWA (dpa-AFX) - At 7:50 a.m. ET on Tuesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening...
► Artikel lesen
Cardinal Health To Buy AdaptHealth's Diabetes Unit, Strive Medical For $360 Mln TotalWASHINGTON (dpa-AFX) - Healthcare services company Cardinal Health, Inc. (CAH) announced late Monday its agreement to acquire the Diabetes Health business of AdaptHealth Corp. (AHCO), as well...
► Artikel lesen